A UF mathematician collaborates with Yale School of Public Health researchers to evaluate the agreement of results between PCR testing and 18 commercially available rapid antigen tests for decision-making in remote work settings on when to end an individual's quarantine.
UF researchers determined how long children remain infectious with the omicron viral variant after receiving a positive test result for SARS-CoV-2.
A look back at the contributions of UF’s Emerging Pathogens Institute to campus-wide COVID-19 research.
UF infectious disease researcher Rhoel Dinglasan was part of a team that devised a saliva-based test for COVID-19. The team's design was one of six winners of the first-ever National Institutes of Health Technology Accelerator Challenge competition.
A new $1.29 million grant from the Global Health Innovative Technology Fund will support EPI malaria investigator Rhoel Dinglasan’s work to develop a novel saliva-based malaria diagnostic test that catches infections even when victims don’t show symptoms.
UF researchers with Emerging Pathogens Institute affiliations have created a rapid, cost-effective point-of-care test for the Zika virus.
